retatrutide mechanism triple agonist glp-1 gip glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Structural insights into the triple

Some researchers continue indefinitely, while others cycle off after reaching their weight loss goals

Potential Benefits: Enhanced Muscle Growth: Direct stimulation of GH production helps increase muscle mass and improves muscle strength by enhancing protein synthesis and promoting new muscle cell growth

As our products are in liquid form and nutrient-dense, they are often far easier to consume than typical food

Brown et al

More Affordable Entry Point Compared to brand-name options like Ozempic or Mounjaro, AltRx is positioned as a more accessible option

While the mechanism is not fully understood, BPC-157 appears to influence dopamine and serotonin systems in ways that may counteract some of the mood changes that occasionally accompany significant dietary restriction